| INTRODUC TI ON
Breast cancer has topped the cancer incidence chart for years and has become the second reason for cancer-related mortality around the world, 1,2 and recurrence is inevitable for chemotherapy-resistant breast cancers. Strengthened and powerful therapies still have not been able to elevate quality of life. 3 American and European medical organizations have emphasized the need for new therapy strategies, to more precisely identify what works in clinical practice, and to generate value-based cancer treatment (https://www.esmo.org/ Guidelines, https://www.asco.org/practice-guidelines). The precise therapy, emphasizing the need for new therapy strategies to better identify which clinical practices would generate value-based cancer treatment, and which therapies target cancer cell regeneration and recurrence, needs targeted to the elimination of the roots for regeneration and recurrence. 4, 5 Sub-colonies of breast cancer stem-like cells (BrCSCs) were blamed for lying dormant for a time 6 and were considered the greatest obstacle to finding a way to cure cancer.
7,8
Controlling the number of cancer stem cells will help constrain cancer recurrence. 9, 10 Normal stem cells are more likely to divide asymmetrically, to sustain the stem cells pool, and functionally, to generate one daughter cell to differentiate. 9, 11, 12 However, division manners were often irregular in cancer stem cells, which tend to divide symmetrically, with unlimited checkpoint. 13, 14 The uncontrolled symmetric division expands the population of stem cells pool and was associated with carcinogenesis and malignancies by a largely unknown mechanism.
The components or suppressive non-coding genes that could regulate the switch between symmetric cell division (SCD) and asymmetric cell division (ACD) will be valuable when trying to repress the self-renewal capacity.
15,16
Long non-coding RNAs (lncRNAs) are lengthy and functional transcripts and were considered as the prospective biomarkers and potential therapeutic targets in cancer diagnosis and treatment. 17, 18 Being implicated in development and growth control, H19 was originally found to be associated with human genetic disorders and recently was identified as one of the major genes in cancer. H19 encodes a 2.6 kb capped, spliced and polyadenylated non-coding RNA, which is predominantly cytoplasmic. 19, 20 H19 is actively involved in all stages of tumorigenesis and is expressed in multiple cancer types. 21 Through inhibiting Let-7 as a molecular sponge, H19 could sequester and regulate the suppressive Let-7, functioning as oncogenic non-coding gene. Regulations of Let-7/ LIN28 axis by altering H19 controlled the fate of CSCs of triple negative breast cancer, 22 but how H19 functioned in CSCs from Lumina A/B breast cancer was unknown. Considering that majority of breast cancer patients featured the phenotype of Lumina A/B; therefore, finding a way to help avoid long-term resistance and recurrence is crucial to find a breast cancer cure. Increased H19 allows cancer cells survive through treatment, 21 and the implicated mechanism of H19 in regulation of BrCSCs' division will reveal prospective approaches to constrain stem cells invasion.
| MATERIAL S AND ME THODS

| Cell culturing, mimics/inhibitors transfection and lentiviral transduction
Breast cancer cell lines of MCF-7, ZR75-1 and HEK-293T were purchased from American Type Culture Collection and were maintained in DMEM (Gibco, Rochester, NY, USA) or in RPMI 1640 Medium (Hyclone, Logan, UT, USA), respectively. About 10% FBS (Gibco), 1%
penicillin and 1% streptomycin (Hyclone) were mixed into medium.
For constructing cells with inhibited H19, cells were transfected with specific anti-H19 inhibitor vector, by using Lipofectamine 3000 as directed in the manufacturer's instruction, and stable cell lines were selected with neomycin (800 μg/mL). and then plated in 6-well ultra-low attachment dishes (1000 cells/mL;
| Quantitative real-time PCR and western blot
Corning Incorporated, Tewksbury, MA, USA). To analyse the self-renewal ability, sphere number of each captured image was counted by using phase contrast microscope (Nikon, Tokyo, Japan).
| Immunofluorescence and EdU staining
Cells were blocked with bovine serum albumin (BSA) at 37°C for For EdU labelling assay, cells isolated from spheres were treated with trypsin and accutase, and were seeded into chamber slides after being filtered into singled cell (Nunc; Thermo Scientific, Carlsbad, CA, USA; Figure S1A ). EdU intensity was detected after cells were incubated with 10uM EdU for staining 24 hours. Detection was performed using Click-iT Plus EdU Alexa imaging Kit (MP 10637; Life Technologies, Carlsbad, CA, USA). The fluorescence images were obtained using an Olympus microscope, and the counting procedure F I G U R E 1 Increased expression levels of Let-7 miRNAs were referred to better prognosis. Kaplan-Meier analysis (https://kmplot.com/ analysis/) was carried out to explore the indicative roles of Let-7 miRNAs in predicating clinical outcomes. Let-7 family members were all subjected for survival analysis, and results of Let-7a (A), Let-7b (B), Let-7c (C), Let-7d (D), Let-7e (E), Let-7f (F), Let-7g (G) and Let-7i (H) were generated and cited. Increased Let-7 family members of Let-7a, Let-7c, Let-7d, Let-7f, Let-7g and Let-7i were related to longer survival time was performed on twenty images that captured from each single experiment ( Figure S1B ). Reporter Assay System (Promega) and normalized to Renilla luciferase activity.
| Luciferase reporter assays
| Statistical analysis
Numerical data were presented as mean ± standard deviation (SD), of three-six independent experiments. Statistical analysis was carried out by using Graph Pad Prism 6 (La Jolla, CA, USA) and Microsoft
Excel software (Redmond, WA, USA). Differences between groups were assessed by using Student's t test or ANOVA individually.
P < 0.05 was statistically significant.
| RE SULTS
| Let-7 family of miRNAs were associated with better prognosis
Correlation between Let-7 family of miRNAs and prognosis of patients with oestrogen receptor-positive breast cancer was stud- Figure 1G ) and Let-7i ( Figure 1H ) were generated and captured. Let-7c, whose overexpression was proved to be positively correlated with Wnt signalling activity inhibition, 7 was identified as one protective indicator when predicating prognosis.
| Wnt signalling was hyperactivated in breast cancer tissues
Wnt signalling factors were analysed for their potential correlation with overall survival (OS) and recurrence-free survival (RFS) by applying Kaplan-Meier analysis (https://kmplot.com/analysis/). Figure S3C ) and CMYC ( Figure S3D) was correlated to either decreased free survival or shorter diseasefree survival.
| Correlation between Wnt signalling and H19 expression
The long non-coding H19 correlates with higher risk of cancer death in multiple cancers, 22, 26 and Heatmap result of TCGA data base revealed the co-overexpression of both H19 and Wnt factors (Figure 2A, Figure S2B ). The validated data from CBIOPORTAL FOR CANCER GENOMIC (https://www.cbioportal.org/) 27,28 further revealed the positive correlation between CTNNB1 and H19
( Figure 2B ), TCF4 and H19 ( Figure 2C ), LEF1 and H19 ( Figure 2D ), from open data of METABRIC and TCGA data base, respectively.
| Axitinib inhibition of Wnt activity and Let-7c overexpression increased the asymmetric cell division in BrCSCs
A subgroup of CSCs tended to divide symmetrically, generating two unique daughter cells, which will inherit full characteristics of mother cells, especially highlighted for their strong ability to selfrenew. Asymmetric division generated two daughter cells with diverse natures, one of which obtained the strong self-renewal ability of mother cell, while another one differentiated into certain phenotypes. EdU label-release assay was applied to define the division modes, 11,13 which could be segregated into daughter cells, as was illustrated in Figure 3A . Division manners could be defined by EdU staining distribution, similar to previous report ( Figure 3B ). Both
Axitinib and Let-7c induced cells to divide asymmetrically (above, Figure 3C ); however, the ratio of symmetric division was inhibited when treating cells with Axitinib or transfecting cells with Let-7c
(below, Figure 3C ). Alternations of division manners resulted in different spheres forming efficiency, and both Axitinib and Let-7c
inhibited the self-renewal ability of BrCSCs ( Figure 3D ,E). Groups treated with 10 uM of Nutlin-3, the MDM2 (mouse double minute 2)
antagonist as p53 pathway activator, were set as the positive group, which could stimulate the asymmetric division. 
| H19 stimulated the symmetric division of BrCSCs
| H19 stimulation of symmetric division was dependent on Let-7 mediation of ESR1 functional pathway
To study the functional roles of oestrogen receptor-related pathways, cells were cultured using medium with charcoal-serum, and functions, and could be mediated by the existence of ESR1.
| The existence of ESR1 was critical for H19 induction of Wnt signalling action
Increasing Let-7c, decreasing H19 and ESR1, all contributed to TCF-4 promoter activity inhibition ( Figure 6A ). When sh-H19 vector was used in combination with Let-7c, ESR1 inhibition or Axitinib, 
| D ISCUSS I ON
Long non-coding RNA regulated miRNAs have attracted much attention since the interactions between non-coding genes paved the way of viewing a whole new mechanistic micro-world of cancer cell biology. 29 Cancer stem cells stand steady and are viewed as the obstacle in the way of curing breast cancer, and up to now, no effective and 
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